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IN the search for more selective tumour inhibitors, p-N-di-(2-chloroethyl)
aminophenylalanine, a mustatd derivative of the natural amino acid phenyla-
lanine, was synthesised by Bergel and Stock (1953, 1954). Biological tests, using
theWalker carcinoma 256have shown this compoundtobemoreactive as agrowth
inhibitor in the L-form, than in the D or DL form (Haddow, 1953, personal
communication). In view ofthis interesting finding, a study has been made ofthe
cytological mechanism by which cessation of tumour-growth is brought about,
and of the relative efficiency of the optical isomers.
Cell Injuries
(i) Walker carcinoma
The effects of the p-N-di-(2-chloroethyl)aminophenylalanine (hereafter to
be referred to as PAM) has been analysed by using the transplantable Walker
carcinoma of the rat. PAM was given by intraperitoneal injection of an arachis
oil suspension, usually 5-6 days after implantation of the tumour graft. The
tumour-bearing rats were killed at intervals varying from 8 to 120 hours. In the
early experiments, PAM was used in the DL form, the dose being 2-5 mg./kg.
After this dose there was a period lasting 24 hours, during which dividing cells
were absent in the tumour. When mitosis reappeared, most of the dividing cells
had excessive chromosome injuries which were difficult to analyse. The same
dose also produced toxic effects in the cell population of the femoral marrow.
For these reasons, the amount ofPAM injected was reduced to 1 mg./Kg. and this
dose was employed throughout except-where otherwise stated.
Comparison of the cellular injuries produced by the DL, L and D forms has
shown that they were the same qualitatively, and they will be described together.
The duration ofthe mitosis-free period after a dose of 1 mg./Kg. PAM is about 16
hours in the subcutaneously growing Walker tumour and 36 hours in the same
tumour growing as an ascites.
The injuries seen in the dividing cells can be grouped into 3 classes; (i)
chromosome fragmentation, (ii) chromosome bridge formation and (iii) post-
metaphase pycnosis of chromosomes. The last type of injury is common in
tumour cells of ascitic fluid, rare in solid tumours. The chromosome fragments
can be most distinctly seen in post-metaphase stages, when they lie between the
two poles towards which the chromosomes move (Fig. 1, 2). Usually the
" acentric " fragments, which lack the spindle fibre attachment, are not included
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in the daughter nuclei: they form the so-called " micronuclei " in the cytoplasm.
The bridge configuration, seen in the ana- and telophase (Fig. 2, 3), is known to
be the result offusion of broken chromosomes in a way differing from that in the
original structure. Both chromosome fragmentation and chromosome bridges
are believed to lead to the degeneration of the injured cell (Koller and Casarini,
1952).
The cytological investigation has shown that the number of injured cells in
mitosis and the amount of injury per cell is greater in tumour samples taken 48
or 72 hours after injection ofPAM than in samples taken 24 hours after treatment
(Fig. 5, 6). On the other hand, the number of dividing cells is less at 48 hours
after treatment than at 24 hours. The reduction in the number of dividing cells
is particularly significant in tumour samples taken 72 hours after administration
of the drug. Those cells which are injured, show very excessive chromosome
fragmentation, as a result of which they undergo degeneration during the post-
metaphase stages and fail to complete mitosis. The process has been described as
anaphase-pycnosis (Koller, 1955).
Another important change which occurs in tumours 72 hours after administra-
tion of PAM is the great increase in the number of histiocytes or stroma cells.
This event is brought about partly by infiltration of these particular cells from
the vascular system and partly by mitosis. Many dividing histiocytes can be
seen in Walker tumours 72 and 96 hours after injection, while dividing tumour
cells become very rare. In these treated tumours two other phenomena have
been observed, namely the great difference in the sensitivity of tumour cells and
histiocytes as shown by the amount of chromosome injuries seen in the cells and
the over-development of the fibrous stroma, due to the differentiation of
histiocytes.
(ii) Other experimental tumours
The effects of the N-mustard derivative of phenylalanine have been studied
on two other rat tumours; the " August " carcinoma and the " Yoshida "
sarcoma. Both tumours were maintained by subcutaneous grafting in particular
inbred strains of rats, and the Yoshida sarcoma was also used as an ascites. The
August tumour was a well differentiated adenocarcinoma (Eisen, 1940) but
now presents the appearance of an undifferentiated sarcoma. The growth ofthese
tumours is slower and less haemorrhagic than that ofthe Walker carcinoma. We
found no inhibition of growth in these tumours after the administration of PAM.
Cytological analysis has shown that the number of injured tumourcells is verylow
indeed, being farfromsufficient to bring about arrest ofgrowth (Table I). Though
the histological structure ofboth ofthese tumours differs from that ofthe Walker
carcinoma, the failure ofgrowth inhibition cannot be attributed to that difference
alone. We observed that the tumour cells ofthe Yoshida ascites showed the same
or nearly the same degree of response measured by chromosome injuries, as the
cells of the " solid " Yoshida tumour, which was grown subcutaneously. It
seems therefore, that the difference in response is due to differences which are
inherent in the malignant cells of these two tumours. That this may be the case is
supported by the fact that the doubling of the dose of PAM greatly increases the
number of abnormally dividing cells in the Walker carcinoma, while the increase
in cellular damage after doubling the dose was negligible when Yoshida sarcoma
was used.
704NITROGEN MUSTARD DERIVATIVE OF PHENYLALANINE
TABLE I.-The Frequency of Injured Cells Observed After the Injection
of the Mustard Derivative ofPhenylalanine (L-isomer).
(100 dividing cells are counted in each tumour).
Percentage of
cells injured.
Dose
Animal. Tumour. (mg./kg.). 24 hours. 48 hours.
T Walker carcinoma (solid) . 1 40 61
Walker carcinoma (ascites) . 0-25 32 51
Rats August carcinoma . 1 7
Yoshida sarcoma (solid) 1 10
l Voshida sarcoma (ascitPs) 0 50 13
Krebs-2 (ascites) . 2 19 12
Mice Ehrlich (ascites) . 2 23 31
Landschutz (solid) . 2 . 16 12
Landschutz (ascites) . 2 . 30 38
The effect ofPAM was also studied on two subcutaneously growing transplant-
able tumours ofmice. Sarcoma 180 showed no response to the drug, no inhibition
of growth was observed, and no chromosome injuries were seen in tumours in
spite of the fact that the doses in some instances were almost lethal (5 mg./kg.).
Similarly no effect was found on another subcutaneously growing tumour, MTO3,
which has originated in our laboratory as a well differentiated mammary gland
carcinoma and is being carried on by transplantation in strain A mice.
Onthe other hand it was foundthat thegrowth of three mouse ascites tumours,
Ehrlich, Krebs-2 and Landschutz, can be inhibited to varying degrees. The
number of dividing cells decreased 3-5 hours after administering the drugs, and
the effect was quite drastic whenthe L isomer was used. The chromosome injuries
observed in the ascites tumour cells are similar to those seen in the cells of the
subcutaneously growing Walker carcinoma (Fig. 7-12). The most sensitive
tumour to PAM treatment was the Landschutz ascites and it was extensively
used for quantitative analysis.
The Effect of PAM Isomers on Tumour Growth
Significant differences were observed by Haddow (1953, personal
communication) on the growth of Walker carcinoma between the DL, L and D
forms of PAM in experiments when the drug was injected 24 hours after the
implantation oftumourgrafts. Similarexperiments were carried out bythe senior
author, using both arachis oil suspensions and aqueous solutions of the sodium
salts ofthe three isomers. The rate of growth was estimated by comparing the
tumour area at different times. These data were obtained by measuring the
length and width of the growing tumour and by calculating the tumour area
in mm2.
The measurements taken on the 7th, 9th and 14th day after injection show
that the growth of the Walker tumour is permanently suppressed in the majority
of tumour bearing animals by the L-isomer, and greatly retarded by the D-form
(Fig. 13). It is interesting to note that the difference in the effects ofthe L and D
forms became noticeable only 7 days after administration.
Thefrequencyofinjured dividing cells 24, 48 and 72hours aftertheadministra-
tion of the three isomers has been determined in Walker tumours, which were 5
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TABLE 1.- Weight of Tumours (Walker) in Grams 13 Days after Implantation
and 12 Days after 1 mg./kg. of Mustard Derivative of Phenylalanine and its
Isomers.
Arachis oil.* Sodium salt.
A ~ ~ ~ ~ ~ ~~~~~ ,'- --
Control. D-. DL-. L-. Control. D-.t L-.
115 44 15 0*5 . 49 16 0*5
90 34 5 0 . 46 12 0
81 30 4 0 . 46 12 0
39 28 3 0 . 46 5 0
37 23 1 0 . 45 5 0
31 20 0 0 . 34 5 0
30 19 0 0 . 34 4 0
28 13 0 0 . 10 2 0
22 10 0 0 . 4 1 0
6 0 0 . - 0 0
* Professor Haddow's test (1953).
t The growth rate of D- and L- treated tumours was the same up to the 6th day after injection-
after that tumours treated with D began to grow.
days old at the time of injection. The data given in Table III show that the
number of injured cells is highest in tumours treated with the L-isomer. The
difference between L and D isomers was particularly significant when the drugs
were administered as arachis oil suspensions. The data also reveal little
difference between the efficiency of L and D isomers in producing mitotic injuries
in established tumours 24 and 48 hours after treatment when the compounds are
administered in the sodium salt form.
Cytological studies have also been undertaken of tumours treated 24 hours
after grafting, but owing to the inflammatory reaction of the host, no reliable
counts ofinjured cells could be made 24 and 48 hours after the administration of
EXPLANATION OF PLATES.
FIG. 1.-Late anaphase in a dividing tumour cell of Walker carcinoma showing a double
chromosome fragment, which lies in the equatorial plate (24 hours after treatment with
D-isomer of the mustard derivative phenylalanine: dose 1 mg./kg.).
FIG. 2.-Acentric chromosomes fragments in a dividing cell of Walker carcinoma (24 hours
after treatment with the L-isomer: dose 1 mg./kg.).
FIG. 3.-Chromosome bridges at late anaphase stage of mitosis. (Walker carcinoma 24
hours after treatment with the D-isomer: dose 1 mg./kg.).
FIG. 4.-Chromosome bridges and acentric fragments in a dividing cell. (Walker carcinoma
24 hours after the DL-form: dose 1 mg./kg.).
FIGS. 5 and 6.-Excessive chromosome injuries, acentric fragments and chromosomes bridges
in two dividing tumour cells; Fig. 5 is 48 hours after; Fig. 6 is 72 hours after treatment
with the L-isomer (dose 1 mg./kg.).
FIG. 7.-Metaphase stage in a cell of Landschutz ascites showing the separation of daughter
chromosomes (untreated).
FIG. 8.-Anaphase in a Landschutz tumour cell 24 hours after treatment with the mustard
derivative of phenylalanine (D-form, 4 mg./kg.). The acentric chromosome fragments
fail to move towards the poles.
FIG. 9.-Late anaphase ofmitosis 12 hours after treatment with L-isomer (4 mg./kg.). Besides
acentric fragments, chromosome bridges are also present. The cell injury is much greater
than shown in Fig. 8.
FIG. 10.-Late anaphase stage 24 hours after treatment with D-isomer (4 mg./kg.) showing
chromosome acentric fragments and bridges.
FIG. 11.-Telophase of a dividing cell 120 hours after treatment with L-isomer ( (4 mg./kg.)
showing excessive chromosome fragmentation and the laying of acentries on the equatorial
plate.
FIG. 12.-Telophase stage 120 hours after treatment with a heavy dose of D-isomer (8 mg./kg.)
showing similar type ofinjury as in Fig. 11.
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FIG. 13.-Graphs showing the rate of growth of Walker carcinoma after the injection with
L- and D-isomers of the mustard derivative of phenylalanine. (Each point represents the
mean of 10 moasurements.)
TABLE III.-Percentage ofInjured Cells at Different Times After
i.p. Injection of 1 mg./kg. Phenylalanine-Muwstard Isomers.
(100 dividing cells were analysed in each case.)
Hours after DL-isomer. . L-isomer. . D-isomer.
injection A A ,A...
(in hours). Oil. Na-salt. Oil. Na-salt. Oil. Na-salt.
24 . 25 27 . 35 39 . 13 34
48 . 37 53 . 73 61 . 7 52
72 . 53 42 . 80 48 . 5 40
PAM. Data obtained in 4 days old tumours (i.e. 72 hours after treatment)
showed that the L isomer is more efficient; 21 cells were abnormally dividing
out of 50 counted as compared with the 13 out of 50 when the D-form was used.
The growth-inhibiting effect of the L and D isomers was also studied on the
Walker carcinoma, 9 days after implantation. While no inhibition was observed
in 10 tumours treated with the D-form, the growth of 4 out of 10 tumours was
arrested by the L isomer.
Although the biological variables in the experiment using the Walker
carcinoma are considerable (cf. Koller and Casarini, 1952), the data obtained
strongly suggest a difference in the effectiveness of the L and D isomers of PAM.
In order to study and to estimate the biological activity ofthese isomers as tumour
inhibitors in more detail a quantitative analysis was made using the Landschutz
ascites tumour, thegrowth andbehaviour ofwhich can be more easily standardised
and controlled than that of the transplantable Walker carcinoma.
Cytological Behaviour and Growth Characteristics of the Landschfitz Ascites.
The tumour was obtained from Dr. G. Klein of Stockholm in 1953, and was
maintained by serial transfers in the inbred C+ strain. The tumour originated
at the end of 1952 in Germany and was identified as a highly undifferentiated
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reticulosarcoma. According to Tjio and Levan (1954) the tumour has a stemline
chromosome number of 46. Our strain of Landschiitz has the same
characteristics as were observed by Bayreuther (1952) and Tjio and Levan (1954).
In three groups, 10 mice of the same age and weight were inoculated with
5 x 106, 20 x 106 and 40 x 106 tumour cells per ml. The growth rate' of the
tumour was measured by the increase in the weight oftumour bearing mice. Fig.
14shows the weight increase after the various inocula. The difference at the three
dose levels appears to be not significant. The survival time of tumour bearing
mice was 17-1, 16*6 and 15-8 days for the 3 inocula respectively.
35-
30~~~~~~~~~~~
a225L/
20- DOSEOF INOCULUM:
0-0 5 X 106 TUMOUR CELLS
+-+ 20 X 106
__ 0X 10,6 "
0
o I
O- 1 2 3
X
5 6 7 8 9 10 1 12 13 14 95 16 17
DAYS AFTER INOCULATION
FIG. 14.-The weight of mice after the inoculation of various doses of cell suspension of
Landschultz ascites.
In order to analyse more accurately the growth rate of this ascites tumour,
the concentration, the total number of tumour cells, and non-tumour cells, and
the mitotic index has been determined at intervals, according to the technique of
Klein (1951), and of Klein and Revesz (1953).
Fig. 15 shows that the number of tumour cell increases till the 270th hour
after inoculation, after which the increase is very small. This coincides with a
corresponding increase in the number ofnon-viable tumour cells: at the terminal
stage the cell population of the ascitic fluid is composed of 12 per cent non-viable
cells.
Effects of L, D and DLforms of PAM on the Landschuitz Ascites Tumours
(i) Survival time
Five groups ofmice, each inoculated with 20 x 106 tumour cells, were injected
intraperitoneally with the three forms of PAM as sodium salt. The dose of the
isomers and the age of the ascites at the time of treatment varied in the different
experiments. The survival time of mice after the various treatments is given in
Table IV. The data show that mice injected with 4 mg./Kg. L-isomer lived
twice as long as the controls. The increase of survival time is less when mice
are treated with the D-isomer, the efficiency of the DL-form being intermediate
between that ofthe L and D isomers. It was also found that the same dose ofthe
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drug is more effective when it is injected into mice soon after inoculation of the
ascites cells. Thus, the development and growth of ascites could be entirely
stopped in some mice, when the L-isomer (4 mg./Kg.) was administered 10 hours
after inoculation of the tumour cells: in others the survival time increased to
36 days. Experiments were also performed in which PAM (L-form) was added to
2000- o,-o TUMOUR CELLS o
+-+ NON TUMOUR CELLS
1BOO0 VIABLE TUMOUR CELLS 100
oo1600- ___ 4%s _J_
- C.
-1400- , 90
L.i ~~~~~~~~~0-0
s 1200- w
J 1000-
0~ -'800-oo
600 0"o 70 ,
400-
200 -60
HOURS AFTER INOCULATION
FIG. 15.-Graphs showing the total number of tumour and non-tumour cells and the per-
centageofviable tumourcells inLandschutz ascites (inoculum 20 x 10! cells). Inthegraphs
each point represents the average of 3 measurements.
cellsuspensions invitro. Mice inoculated with pre-treated ascitessuspensionskept
allve for 9 weeks and at autopsy no signs of tumours were found.
The data of Table IV show furthermore that the effect depends also on the
dose ofthe drug: 2 mg./Kg. was found to be less effective in prolonging life than
4 mg./Kg.
TABLE IV.-Survival Time of Mice After Treatment with PAM
(In each experiment 20 x 106 cells were inoculated.)
Age of
ascites.
10 hours
3 days
6 days
3 days
3 days
Number of
injections.
-1
1
1
*4
Survival times in days
after treatment.
L-form. D-form. DL-forlm.
* 36-1*
30-8 25-3 27-4
27-5
21-8 19-5
30-2 24*2 27-9
Control: Survival time 15- 8 days.
* 5 out of 10 treated mice were without a.scites after treatment.
(ii) Rate ofgrowth
Mice were inoculated with 20 x 106 tumour cells and the three isomers were
injected 3 days later (dose 4 mg./Kg.). The weights of mice were taken every
second day and the data obtained are illustrated in Fig. 16. It can be seen that
the growth of ascites was arrested by the drugs up to 12 days, and the effects of
Dose
(mg.).
4
4
4
2
1
(daily)
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the three forms were the same. Differences, however, became apparent after
that date and the measurements showed that the L-isomer was most effective
in retarding the growth of the intraperitoneal effusion.
35 -0o D. FORM
+-+ DL. FORM
r . L. FORM
30- O_O_°
~2
ui 0~~~ O25-I
1
/
0kss/+,,
TREArPEEmr
15-
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34
DAYS AFTER INOCULATION
FIG. 16.-The weight of mice inoculated with 20 x 106 cells and treated on the 3rd day with
the various isomers of the mustard derivative of phenylalanine (dose 4 mg./kg.).
(iii) Number and viability of-tumour cells
An increase in the weight of tumour bearing mice treated with 4 mg./Kg.
L-isOmer of PAM was observed on the 25th day: before that day the weight
remained 18-20 g. In order to analyse the cytological mechanism responsible
for the delay in rate of growth after administration of the drug, the total number
of tumour cells was estimated by sampling the cell composition of the treated
ascites every second day. The data obtained are given in Fig. 17. The
concentration and number of tumour cells remain stationary at about 20 or
,-3
O 0
0 TUMOUR CELLS l O
1800- +-+ NON TUMOUR CELLS _90
VIABLE TUMOUR CELLS
J1600- /
° 600 o -5~~~~~~00 'M
1400 J 0
12000 /70
-~~~~~~~~~~~~~~~~~~J
_31000
,
FIG.~~~L 17. Th /rph shwtettlnme0ftmu ndnntmuel,adtepr
80
600
400- ~ ~ ~ ~ ~ ~~ ILa
0 -40 c
200- ~
100 200 300 400 .500 600 700 800
HOURS AF-TER INOCULATION
FIG. 17.-The graphs show the total number of tumour and non-tumour cells, and the per.
centage of viable tumour cells in the Landschutz ascites (inoculum 20 x 106 cells) after the
intraperitoneal injection of the L-form of the drug (dose 4 mg./kg.). (Each point represents
the average of 3 measurements).
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30 x 106 up to 25 days (600 hours), after which there is an increase lasting 5 days.
The cessation is due partly to failure of cell division of treated cells and partly to
the elimination of cells which have undergone abnormal mitosis. There was a
great drop in the number of viable tumour cells in ascites treated with the drug
10-5 days previously, and in the same sample 24 per cent of the cell population
was found to be composed of pycnotic, degenerating cells.
(iv) Chromosome injuries
Mice inoculated with 20 x 106 tumour cells, were injected 3 days later with
PAM. The cytological analysis has shown that the tumour cells after having
been treated with the various optical forms undergo abnormal mitosis, which is
due to injuries of the chromosomes (Fig. 7-12). The effectiveness of the three
forms in producing abnormalities in dividing cells was measured by counting the
number of abnormal post-metaphase stages. The data obtained are given in
Table V. The percentages ofabnormal cells after treatment with L and D isomers
are compared at two doses and illustrated in Fig. 18. It seems that the two
00
100- 1OO | o ~~~~~~0o 4 mg/Kg
90| mg/Kg
80 60 FO40
0.
* 400 0 0.o,,. -:=::$i
30-
0 24 48 72 96 120 144
HOURS AfrER TREATMENT
FIG#. 18.-Graph showing the frequency of Landschuitz tumour cells with chromosome injuries
after treatment with different doses of L and D-isomers.
isomers are equally efficient in producing mitotic abnormalities when administered
at a dose of 1 mg./kg. With higher doses, the L-isomer appears to produce more
abnormally dividing cells than the D-isomer.
DISCUSSION
The mustard derivative of phenylalanine (PAM) has been found in our experi-
ments to affect the growth of the Walker carcinoma when administered 24 hours
after the implantation ofthe tumour. PAM was also tested by Larionov and his
colleagues (1955) on another transplantable tumour. They used the DL form
(Sarcolysine) which has been synthesised in the U.S.S.R. independently of
Bergel andStock (1953). The tumour used by Larionov was sarcoma 45 which was
produced by 9, 10-dimethyl-1,2-benzanthracene. Sarcoma 45 kills the tumour-
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bearing animals on the 25-30th day after implantation: i.e. its rate ofgrowth is
slower than that of the Walker carcinoma. Larionov reported that a single
intraperitoneal injection of 15 mg./kg. of the drug was sufficient to suppress the
growth of this particular tumour completely. As a result of treatment the histo-
logical structure of sarcoma 45 undergoes a drastic change: the small residual
nodule left at the site ofgrowth, was found to be composed merely of connective
tissue stroma devoid of tumour cells.
The L-isomer has also been tested against the Harding-Passey melanoma
grown in mice of dba line-i. The growth of 9 days old melanoma was arrested
by an intraperitoneal injection of the L-form of PAM (dose 14 mg./kg.) (Luck,
1956). In the present investigation complete regression as well as temporary
inhibition ofgrowth has been obtained with PAM in the Walker, Ehrlich, Krebs
and Landschutz ascites tumours. The suppression of growth was always found
to be preceded by cell injuries, very similar to those seen in the Walker carcinoma
after HN2 treatment (Koller and Casarini, 1952).
Comparison of the various effects which appear after the administration of
the three isomers of PAM indicate that the L-form is the most effective, PAM
in this form stops the development of Walker carcinoma at least in 80 per cent of
the tumour-bearing rats. Similar observations were made when the effects ofthe
various isomers on thegrowth rate of the Landschiitz tumour and on the survival
time of tumour-bearing mice were compared: in both respects the action of the
L isomer was greater than that of the D or DL forms.
On the other hand, when tumour cells with chromosome injuries are used
as the criteria ofactivity, the difference between the various isomers appear to be
too small to account for the significant differences in growth rate. The number of
injured cells in tumours treated with L, D, and DL forms appears to be similar
except when the drugs are administered as arachis oil suspensions, in which case
the superiority of the L isomer becomes more obvious. It seems therefore that
growth inhibition is not due to the death of tumour cells only which is brought
about by chromosome injuries: other events, e.g. suppression of mitosis, cell
pycnosis in resting stage, stromal reaction etc. which follow the administration
of the drugs also play a role in growth suppression. It has been observed that
these processes differ in expression, intensity, time of onset and duration in a
6-7 days old rapidly growing Walker carcinoma treated with the various isomers
of PAM. At present, however, no method is available to compare these
phenomena on a quantitative basis.
Furthermore, it has been found that 24 or 48 hours after implantation the
migrating and proliferating cells of the Walker carcinoma graft are under the
influence of an inflammatory local reaction and that during this process the
effects of drugs (e.g. HN2) differ in type and intensity from those effects which
the same drugs produce in a 6-7 days old well-established tumour (Koller,
unpublished). Some evidence has been obtained which seems to indicate that in
a young tumour graft the onset of mitosis suppression occurs 6 hours later after
the administration of the D isomer than after that of the L-form of PAM. Such
a delay during the crucial period of tumour establishment (" take") would alone
be sufficient to account for the difference in the rate of growth at later stages of
tumour development.
The mean lethal dose (LD50) in male rats was found to be about 10 mg./kg.
for the L-form of PAM while it was 30 mg./kg. for the D-isomer (Boyland and
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Seeking, personal communication). The difference made it possible to increase
the dose of D-isomer in some experiments with the aim of producing the same
number of cells with chromosome injuries, and the same degree of growth inhibi-
tion in the Walker carcinoma as was found after the administration of the L-
isomer. The data obtained suggests that 3 mg./kg. ofD is equivalent to 1 mg./kg.
of L in producing the same number of cells with chromosome injuries in the
Walkertumour 24 and 48 hours after intraperitoneal injection. In order, however,
to suppress the growth of a 24 hour tumour graft, it was necessary to increasethe
dose ofD isomer to 5 times that ofL-form.
Thus the various biological tests, when they are considered together, strongly
suggest that the L-form of PAM is more active as a growth-inhibitor of some
particular transplantable tumours than either the D or DL forms. The question
naturally arises as to what are the differences between the isomers which could
account for the differences in biological activity. If for instance there were a
difference in the rate oftransportation, excretion, etc. between the L and D forms,
they might be absorbed differentially by the tumour cells. In the present
investigation some differences have been noted which would suggest that the
physical properties of the isomers may play a role. It was mentioned previously
that the difference in the number ofinjured cells was greater when the two isomers
were administered in arachis oil suspensions and not in the sodium salt form
(Table III). Similarly at high dose levels the difference between the L and D
formsinproducing cellinjuries in the Landschutz ascitestumour, wasgreaterthan
at low dose level (Table V and Fig. 18).
TABLE V.-Percentage of Anaphases with Fragments in Landschiutz Ascites
Treated with the Isomers of PAM.
(100 dividing cells were counted in each cell).
Per cent of cells with fragments.
Dose Isomeric ,
(mg./kg.). form. 24 hr. 48 hr. 72 hr. 96 hr. 120 hr. 144 hr.
8 f L 64 85 81 76 -
\D . 55 71 76 78 -
r L 45 69 72 76 71 60
4 D 42 79 67 61 66 51
L DL . 40 73 - 46 65
2 . L . 42 - - -
f L 30 38 44 40 38 20 1-~ D 31 40 42 37 35 18
0.4 . L . 9 19 4 9 6 6
These few facts seem to suggest that the mustard derivative of phenylalanine
may act in ceLl metabolism as the L-isomer: i.e. the D form must be racemised
before it can interact with cellular enzymes or intermediates. It is, however,
possible that the D-form of PAM is active as such, but owing to its stereochemical
configuration the incorporation of this isomer into cellular metabolites is slow.
Both processes would introduce a time lag: some loss would occur ifracemisation
were involved since this, would result in the lower biological activity of the D
isomer observed in our experiments. The differences seen in the time of onset of
713714 P. C. KOLLER AND U. VERONESI
mitosis suppression in a 1 day old Walker tumour graft after the administration
of L and D isomers suggests that this may be the case.
SUMMARY
1. A nitrogen mustard derivative of phenylalanine inhibits the growth of
certain experimental tumours in rats and mice.
2. Thegrowthinhibition is initiated byinjuries to the chromosome mechanism,
which leads to the death of tumour cells.
3. Cells in malignant effusions are more sensitive to the drug than cells in the
subcutaneous growing solid tumour.
4. The L-isomer is more effective as an inhibitor of the growth of the Walker
carcinoma than the D or DL forms.
5. In producing chromosome injuries in the Walker tumour cells the L-isomer
is 3 times more active than the D form and it is 5 times more effective as a growth
inhibitor of this tumour than the D-isomer.
6. The difference in activity between the L and D or DL forms is greater when
the drug is administered in arachis oil suspension.
7. The drugincreases the survival time ofmiceinoculatedwith the Landschutz
ascites. tumours. The L-isomer was the most effective, prolonging life to 36-5
days as compared with 15-5 days for control mice. The D and DL-forms were less
effective in this respect than the L-form.
8. In both the Walker carcinoma and the Landschiitz ascites, the differences
shown by the three isomers on growth inhibition becomes measurable 7 and 12
days respectively after administration of the drug.
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